Menu
Corena plays a crucial role in providing early access and unlicensed medicines through our partnerships with esteemed vital players. Our distribution network extends across Turkey and various nations while our partnerships broaden essential medicines’ availability and timely delivery.
As part of our global distribution services, Corena brings rare disease drugs to patients and with each delivery, we are not just transporting a product but conveying hope and the promise of improved health. Our duty is to make sure that revolutionary treatments reach those who need them most.
Corena This revolutionary product offers a new lease on life for those battling Thyroid Eye Disease. We’re turning the hide against this condition through our global distribution network
This life-altering neuroblastoma therapy, delivered through our global distribution services, symbolises our dedication to making a difference in the lives of those afflicted by this condition.
A beacon of hope for those battling multi-drug resistant HIV disease. This remarkable product is transforming the landscape of HIV treatment.
Early Access Programs (EAPs) provide a valuable route for patients to gain access to treatments that are not yet available through standard courses. Through strategic partnerships with manufacturers and CROs, Corena works to facilitate these programs in Turkey. We aim to bridge the gap between pharmaceutical innovation and patient needs, providing access to new treatments before full regulatory approval.
